TrialCancer research and treatment2018

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).

Yoon Ji Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.